Phase I trial with a novel oral NF-κB/STAT3 inhibitor RTA 402 in patients with solid tumors and lymphoid malignancies
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: D. S. Hong, R. Kurzrock, J. G. Supko, D. P. Lawrence, J. J. Wheler, C. J. Meyer, J. W. Mier, M. Andreeff, G. I. Shapiro, B. J. Dezube
Language: English
Topic: NF-κB Signaling Pathways
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2305512101